Biologics Spine Top Stories Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics Business byJosh SandbergAugust 10, 2023
Financial Top Stories Augmedics Strengthens AR/AI Portfolio With Planned Acquisition of Surgalign Digital Health Assets byJosh SandbergJuly 31, 2023
Biologics Spine Xtant Medical Wins Auction for Surgalign’s Hardware and Biologics Business byJosh SandbergJuly 28, 2023
Financial Top Stories Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy Code byJosh SandbergJune 20, 2023
Neuro Spine Surgalign Announces Release of HOLO™ AI Insights for Neurovascular Research byJosh SandbergMay 8, 2023
Spine Top Stories Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies byJosh SandbergMay 3, 2023
Financial Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results byJosh SandbergMarch 30, 2023
Spine Top Stories Surgalign Launches Next Generation Software for its HOLO Portal™ Surgical Guidance System and Expands Surgical Tool Integration to Drive Use Case Adoption byJosh SandbergMarch 20, 2023
Spine Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging byJosh SandbergMarch 13, 2023
Spine Top Stories Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas byJosh SandbergMarch 3, 2023
